# Impact of Ascorbic Acid in the Prevention of Vancomycin Induced Nephrotoxicty

> **NCT03921099** · PHASE4 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 40 (estimated)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** Ascorbic Acid

## Key facts

- **NCT ID:** NCT03921099
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-17
- **Primary completion:** 2020-07
- **Final completion:** 2020-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03921099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03921099, "Impact of Ascorbic Acid in the Prevention of Vancomycin Induced Nephrotoxicty". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03921099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*